Editorial Team
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Editorial Team | Updated : July 24, 2014 11:20 AM IST
A signal that promotes insulin secretion and reduces hyperglycemia in a type 2 diabetes animal model is enhanced by the inhibition of a novel enzyme discovered by CHUM Research Centre (CRCHUM) and University of Montreal researchers. The team is part of the Montreal Diabetes Research Center and their study was directed by researchers Marc Prentki and Murthy Madiraju. Marc Prentki, Director of the Montreal Diabetes Research Centre and Professor at the University of Montreal, said despite significant research on the mechanisms implicated in insulin secretion, the signal molecules involved in this process remained enigmatic; the identification of these signals is necessary to develop better therapeutics against diabetes. (Read: 10 diet dos and don'ts for diabetics)
Murthy Madiraju, Researcher at the CRCHUM, said when sugar is being used by the insulin secreting pancreatic beta-cell, it produces monoacylglycerol, a fat-like signal and this is associated with insulin release into blood; they found that the production of monoacylglycerol is essential for glucose-stimulated insulin secretion by the beta-cell. Importantly, the research team discovered that an enzyme called alpha/beta hydrolase domain-6 (in short ABHD6) breaks down monoacylglycerol and thus negatively controls insulin release. (Read: 10 ways to control diabetes naturally)
These researchers said that 'an ideal drug for type-2 diabetes would increase insulin levels in blood by enhancing the beta cells response to glucose only when it is elevated and also increase the sensitivity of body tissues to insulin; this is precisely what ABHD6 inhibition does and thus we have identified a unique new target for type 2 diabetes.' (Read: 10 healthy resolutions for diabetics)
The study has been published in the journal Cell Metabolism.
What is type 2 diabetes?
Type 2 diabetes is the more commonly found form of diabetes. It is an endocrine disorder where the pancreas may be producing insulin but your body may not be able to use it properly. This cause a rise in blood sugar levels. Due to the modern lifestyle where people are mostly sedentary, eat processed foods and lead a stressful life, type 2 diabetes is fast becoming the most common disease around the world with India leading the pack. (Read: Tips to live well with Type 2 Diabetes)
You may also like to read:
With inputs from ANI
For more on diabetes, check out our diabetes section and Diabetes page. Follow us on Facebook and Twitter for all the latest updates! For daily free health tips, sign up for our newsletter. And to join discussions on health topics of your choice, visit our forum.
